GlassScriptPhysician profile
Brandi P Derrick
NPI 1245465178
$2,652.58
in general payments reported to CMS, 2019-2025
38 companies · $664 in 2025
The $664 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $935 · 2020: $257 · 2022: $247 · 2023: $267 · 2024: $283 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,213.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $347.40 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $306.16 | 2019-2025 | |
| Abbott Laboratories | $288.43 | 2023-2025 | Freestyle Libre 3 |
| Amgen INC. | $269.46 | 2019-2025 | Evenity, Repatha, Otezla |
| Abbvie INC. | $201.73 | 2023-2025 | Vraylar, Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $193.31 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Astellas Pharma US INC | $110.50 | 2019-2025 | Veozah |
| Exact Sciences Corporation | $79.52 | 2024-2025 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $73.48 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $59.60 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $59.13 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.20 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $47.99 | 2019-2020 | |
| Lilly USA, LLC | $40.57 | 2019-2025 | Mounjaro, Zepbound |
| Xeris Pharmaceuticals, INC. | $38.91 | 2022-2023 | Gvoke Hypopen |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandi Derrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.